DuOS (Duloxetine) 20, 30 & 60mg Capsules

When managing complex conditions like Diabetic Peripheral Neuropathic Pain (DPNP) and major depressive symptoms, patients need a treatment backed by definitive clinical success. DuOS (Duloxetine) 20mg, 30mg, and 60mg capsules offer a powerful, dual-action therapeutic approach. By addressing both nerve pain pathways and chemical imbalances, DuOS stands out as a premier clinical choice for patients looking to reclaim their quality of life.

• Superior Pain Reduction vs. Pregabalin & Gabapentin: Managing neuropathic pain requires strong, targeted intervention. Clinical data over a 6-month study ($n = 1523$) reveals that Duloxetine (DuOS) is statistically superior to both Pregabalin and Gabapentin in lowering Brief Pain Inventory (BPI) average pain severity scores.

• Outperforms Traditional SSRI Therapy: In a pooled analysis of six fixed-dose studies, DuOS therapy proved to be significantly more effective than standard SSRIs (like fluoxetine and paroxetine at 20mg/day), demonstrating higher remission rates ($HAM-D \le 7$) across diverse patient groups.

• Proven Clinical Remission: For patients dealing with severe depressive symptoms ($HAM-D \ge 18$), data confirms a clear clinical hierarchy of efficacy: $PBO < SSRI \le DLX$, proving that DuOS delivers robust, reliable results where standard treatments fall short.

• Versatile Strength Options: Available in 20mg, 30mg, and 60mg capsules, allowing healthcare providers to seamlessly tailor the dosage to each patient’s specific therapeutic needs.